Dagmara Baraniak

Dr. Dagmara Baraniak

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
DBDagmara Baraniak
Dagmara Baraniak
KKKarol Kacprzak
Karol Kacprzak
LCLech Celewicz
Lech Celewicz

1 June 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JZJoanna Zeidler
Joanna Zeidler
DBDagmara Baraniak
Dagmara Baraniak
TOTomasz Ostrowski
Tomasz Ostrowski

31 May 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
DBDagmara Baraniak
Dagmara Baraniak
JBJerzy Boryski
Jerzy Boryski
This review covers studies which exploit triazole-modified nucleic acids in the range of chemistry and biology to medicine. The 1,2,3-triazole unit, which is obtained via click chemistry approach, shows valuable and unique properties. For example, it does not occur in nature, constitutes an additional pharmacophore with attractive properties being resistant to hydrolysis and other reactions at physiological pH, exhibits biological activity (i.e., antibacterial, antitumor, and antiviral), and can be considered as a rigid mimetic of amide linkage. Herein, it is presented a whole area of useful artificial compounds, from the clickable monomers and dimers to modified oligonucleotides, in the field of nucleic acids sciences. Such modifications of internucleotide linkages are designed to increase the hybridization binding affinity toward native DNA or RNA, to enhance resistance to nucleases, and to improve ability to penetrate cell membranes. The insertion of an artificial backbone is used for understanding effects of chemically modified oligonucleotides, and their potential usefulness in therapeutic applications. We describe the state-of-the-art knowledge on their implications for synthetic genes and other large modified DNA and RNA constructs including non-coding RNAs.

1 September 2013 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MLMarta Lewandowska
Marta Lewandowska
Piotr RuszkowskiPiotr Ruszkowski
Piotr Ruszkowski
DBDagmara Baraniak
Dagmara Baraniak
ACAnna Czarnecka
Anna Czarnecka
NKNatalia Kleczewska
Natalia Kleczewska
LCLech Celewicz
Lech Celewicz

8 June 2019 in Nucleosides, Nucleotides & Nucleic Acids
Verified
Journal Article
Closed access
DBDagmara Baraniak
Dagmara Baraniak
DBDaniel Baranowski
Daniel Baranowski
Piotr RuszkowskiPiotr Ruszkowski
Piotr Ruszkowski
JBJerzy Boryski
Jerzy Boryski
The fluorinated nucleoside dimers with a 1,2,3-triazole linkage are novel compounds within the field of bioorganic chemistry. We report on the synthesis and properties of two groups of nucleoside dimers analogs possessing a different arrangement of the 1,4-disubstituted 1,2,3-triazole linkage. Based on analysis of the 3JHH, 3JH1′C2, and 3JH1′C6 we estimated conformational preferences of sugar part and orientation around glycosidic bond. These compounds show moderate anticancer activity, with cytostatic studies in three different cancer cell lines.

27 December 2018 in Nucleosides, Nucleotides & Nucleic Acids
Verified
Journal Article
Closed access
LMLucyna Michalska
Lucyna Michalska
DWDariusz Wawrzyniak
Dariusz Wawrzyniak
ASAgnieszka Szymańska-Michalak
Agnieszka Szymańska-Michalak
JBJan Barciszewski
Jan Barciszewski
JBJerzy Boryski
Jerzy Boryski
DBDagmara Baraniak
Dagmara Baraniak
We describe a simple method for the synthesis of modified dinucleosides containing pyrimidine nucleoside analogues (2’-deoxyuridine, thymidine and 5-fluoro-2’-deoxyuridine). Six different dimers with a 1,2,3-triazole linkage were obtained by azide–alkyne 1,3-dipolar cycloaddition (click reaction), starting from propargylated 2’-deoxyuridine and 5’-azido-nucleoside derivatives. Their cytotoxic activity was tested in five human cancer cell lines: cervical (HeLa), high grade gliomas (U-118 MG, U-87 MG, T98G), liver (HepG2), and normal human fibroblast cell line (MRC-5) using the sulforhodamine B (SRB) assay. The experiment showed that the obtained dimers with a 1,2,3-triazole moiety were very stable compounds, also in the physiological-like media, and had no anticancer activity.